COVID-19 Updates
Conference Coverage
Saltwater gargling may help avoid COVID hospitalization
Hospitalization rates in the low- (18.5%) and high- (21.4%) saline groups were significantly lower than in the reference control population.
From the Journals
Long COVID and mental illness: New guidance
“Long COVID is real, and mental health conditions do not cause long COVID.”
From the Journals
Sensory comeback: New findings show the path to smell and taste recovery after COVID
“... There are still people suffering from it. ... It really has a significant psychological impact.”
From the Journals
A new long COVID explanation: Low serotonin levels?
The study found lower serotonin levels in long COVID patients, compared with patients who were diagnosed with acute COVID-19 but who fully...
Feature
Second infection hikes long COVID risk: Expert Q&A
There are people who think, “This is a nothing-burger anymore,” or “It’s not an issue anymore.” It’s still happening with the current variants.
Article
Keep COVID-19 vaccination on your patients’ radar
Waning vaccine-induced immunity and viral mutation require updated COVID-19 interventions. Here’s the latest on vaccines and immunization...
From the Journals
People with long COVID don’t show signs of brain damage
“The findings thus suggest that post-COVID condition is not the result of ongoing infection, immune activation, or brain damage.”
From the Journals
Serious mental illness tied to 50% higher all-cause mortality risk after COVID
“From a public health perspective, our study has emphasized the need for early and timely preventative interventions (e.g. vaccination) for the...
From the Journals
Nirmatrelvir-ritonavir ineffective at reducing most post-COVID conditions
However, thromboembolic events were reduced.
News
mRNA vaccine cuts COVID-related Guillain-Barré risk
“While Guillain-Barré is extremely rare, people should be aware that having a COVID infection can increase their risk of developing the disorder,...
News
Right under our noses
Study results suggest that perhaps we should be giving more attention to the development of nasal vaccines.